of the federative republic of brazil, the arab republic of egypt, the republic of india, the islamic republic of iran, the people's republic of china, the federal democratic republic of ethiopiaia has something to surprise its foreign partners, for example, in the fmba, in order to increase the effectiveness of scientific research, introduced a cluster approach and technological platforms. they allow you to gather a team for a specific task to speed up development. over the course of a year, the agency managed to create more than 250 new vaccines and medicines. of particular importance are, of course, antidotes against toxic substances, and new radioprotectors. these are new systems for radiochemical-biological defense troops; in the twenty-third year we have developed a unique, the world's first allergy vaccine against birch pollen and cross food allergens, we have developed personalized oncology vaccines that can be used for colorectal cancer; similar studies are now underway for different types of melanomas. in addition to knowledge, beautiful theory, there is an element of chance, something that we constantly talk about, and it is quite large. the russian academy of scien

also today at the general meeting. the republic of india, the islamic republic of iran, the people's republic of china, the federal democratic republic of ethiopiapublic of south africa, today we were able to communicate with foreign specialists who are happy to adopt the experience of our russian scientists, for example, now in kyrgyzstan they will begin to grow varieties of p . it is also worth noting that academicians, rana, members of the correspondent, they closely cooperate with the federal medical and biological agency, they work in close conjunction. we have created a network of widespread technological platforms, these are proven technological algorithms that enable products with similar mechanisms of action quite quickly. develop according to certain standardized stereotypical models, and we have created many such platforms in just last year we have more than 250 products protected by intellectual property protected as the right of the russian federation, these are new vaccines, these are new medicines, in the twenty-third year we have developed a unique, the world's first allergy vaccine, we have developed. i would like to note that y

india, islamic republic of iran, people's republic of china, federal democratic republic of ethiopia, south african republic. russia has something to surprise its foreign partners. for example, the fmba, in order to increase the productivity of scientific research, introduced a cluster approach and technological platforms. they allow gather a team for a specific task to speed up development. in a year at the agency i succeeded. analyzed oncovaccine, which can be used for colorectal cancer; now similar studies are underway for different types of melanomas and gleoblastomas. unique methods for treating serious diseases and basic scientific research were discussed in detail at the annual general meeting of the department of medical sciences . it took place at the loginov moscow clinical scientific and practical center. it's a great honor for us that it's in our institution held a general meeting of the department of medical sciences, of course, this serves as a reflection of the development processes that are taking place in moscow healthcare, the fact that we are moscow institutions. me